BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6255934)

  • 1. Significance of NADH-vanadate-oxidoreductase of cardiac and erythrocyte cell membranes.
    Erdmann E; Werdan K; Krawietz W; Lebuhn M; Christl S
    Basic Res Cardiol; 1980; 75(3):460-5. PubMed ID: 6255934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [NADH-vanadate-oxidoreductase in emotional-pain stress and its possible role in the regulation of Na+-K+-ATPase activity].
    Iakushev VS; Makoed OB; Davydov VV; Shkopinskiĭ EA
    Ukr Biokhim Zh (1978); 1985; 57(6):34-8. PubMed ID: 3000037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purified cardiac cell membranes with high (Na+ + K+)ATPase activity contain significant NADH-vanadate reductase activity.
    Erdmann E; Krawietz W; Philipp G; Hackbarth I; Schmitz W; Scholz H; Crane FL
    Nature; 1979 Nov; 282(5736):335-6. PubMed ID: 228200
    [No Abstract]   [Full Text] [Related]  

  • 4. Vanadate binding to the (Na + K)-ATPase.
    Robinson JD; Mercer RW
    J Bioenerg Biomembr; 1981 Dec; 13(5-6):205-18. PubMed ID: 6277881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of red cell Ca2+-ATPase by vanadate.
    Bond GH; Hudgins PM
    Biochim Biophys Acta; 1980 Aug; 600(3):781-90. PubMed ID: 6447513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanadate inhibits the red cell (Na+, K+) ATPase from the cytoplasmic side.
    Cantley LC; Resh MD; Guidotti G
    Nature; 1978 Apr; 272(5653):552-4. PubMed ID: 211419
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of several ligands on the potassium-vanadate interaction in the inhibition of the (Na+ + K+)-ATPase and the Na+, K+ pump.
    Beaugé L; Berberian G
    Biochim Biophys Acta; 1983 Jan; 727(2):336-50. PubMed ID: 6301556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vanadate on intracellular reduction equivalents in mouse liver and the fate of vanadium in plasma, erythrocytes and liver.
    Bruech M; Quintanilla ME; Legrum W; Koch J; Netter KJ; Fuhrmann GF
    Toxicology; 1984 Jun; 31(3-4):283-95. PubMed ID: 6564811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of (Na,K)-ATPase by tetravalent vanadium.
    North P; Post RL
    J Biol Chem; 1984 Apr; 259(8):4971-8. PubMed ID: 6325413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of lithium to counteract vanadate-induced inhibition of red blood cell membrane Na+, K+-ATPase.
    MacDonald E; LeRoy A; Linnoila M
    Lancet; 1982 Oct; 2(8301):774. PubMed ID: 6125845
    [No Abstract]   [Full Text] [Related]  

  • 11. Vanadate inhibition of the Ca2+-ATPase from human red cell membranes.
    Barrabin H; Garrahan PJ; Rega AF
    Biochim Biophys Acta; 1980 Aug; 600(3):796-804. PubMed ID: 6447514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of added orthovanadate to vanadyl and high-molecular-weight vanadates by Saccharomyces cerevisiae.
    Willsky GR; White DA; McCabe BC
    J Biol Chem; 1984 Nov; 259(21):13273-81. PubMed ID: 6386812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disparity between effects of vanadate (V) and vanadyl (IV) ions on (Na+-K+)-ATPase and K+-phosphatase in skeletal muscle.
    Vyskocil F; Teisinger J; Dlouhá H
    Biochem Biophys Res Commun; 1981 Jun; 100(3):982-7. PubMed ID: 6268091
    [No Abstract]   [Full Text] [Related]  

  • 14. A vanadate-stimulated NADH oxidase in erythrocyte membrane generates hydrogen peroxide.
    Vijaya S; Crane FL; Ramasarma T
    Mol Cell Biochem; 1984 Jun; 62(2):175-85. PubMed ID: 6087122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dog kidney (Na+,K+)-ATPase is more sensitive to inhibition by vanadate than human red cell (Na+,K+)-ATPase.
    Bond GH; Hudgins PM
    Biochim Biophys Acta; 1981 Sep; 646(3):479-82. PubMed ID: 6269617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanadate effect on the Na,K-ATPase and the Na-K pump in in vitro-grown rat vascular smooth muscle cells.
    Searle BM; Higashino H; Khalil F; Bogden JD; Tokushige A; Tamura H; Kino M; Aviv A
    Circ Res; 1983 Aug; 53(2):186-91. PubMed ID: 6309430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanadate interaction with the Na, K-ATPase. An assay of serum vanadate based on the displacement of (48V) vanadate from Na, K-ATPase.
    Hansen O
    Basic Res Cardiol; 1980; 75(3):455-9. PubMed ID: 6255933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanadium inhibition of human parietal lobe ATPases.
    Janiszewska G; Lachowicz L; Jaskólski D; Gromadzińska E
    Int J Biochem; 1994 Apr; 26(4):551-3. PubMed ID: 8013740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vanadate on isolated vascular tissue: biochemical and functional investigations.
    Fox AA; Borchard U; Neumann M
    J Cardiovasc Pharmacol; 1983; 5(2):309-16. PubMed ID: 6188908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commercial ATP containing traces of vanadate alters the response of (Na+ + K+) ATPase to external potassium.
    Beaugé LA; Glynn IM
    Nature; 1978 Apr; 272(5653):551-2. PubMed ID: 211418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.